| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.83.3.836 |
| P698 | PubMed publication ID | 1999035 |
| P2093 | author name string | Elwood PC | |
| O'Brien JR | |||
| Baker IA | |||
| Sweetnam PM | |||
| Yarnell JW | |||
| Bainton D | |||
| Whitehead PJ | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart disease | Q190805 |
| lymphocyte | Q715347 | ||
| collaboration | Q1145523 | ||
| P304 | page(s) | 836-844 | |
| P577 | publication date | 1991-03-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies | |
| P478 | volume | 83 |
| Q24297061 | A hepatocyte nuclear factor-3 site in the fibrinogen beta promoter is important for interleukin 6-induced expression, and its activity is influenced by the adjacent -148C/T polymorphism |
| Q43833293 | A pharmacoepidemiological assessment of the effect of statins and fibrates on fibrinogen concentration |
| Q40818460 | A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study |
| Q71763902 | A unifying theory of atherogenesis |
| Q44733540 | Acute cardiopulmonary effects induced by the inhalation of concentrated ambient particles during seasonal variation in the city of São Paulo. |
| Q81405287 | Acute hemoconcentration during psychological stress: assessment of hemorheologic factors |
| Q51482141 | Acute phase and opsonin response in cardiac surgery patients: influence of underlying cardiac disease. |
| Q99606209 | Advanced Constitutive Modeling of the Thixotropic Elasto-Visco-Plastic Behavior of Blood: Description of the Model and Rheological Predictions |
| Q33705858 | Air pollution and mortality in Barcelona |
| Q47918605 | Altering molecular mechanisms to prevent sudden arrhythmic death |
| Q38297868 | Angiotensin converting enzyme inhibitors--do they have an anti-ischemic action? |
| Q34441606 | Anticoagulation and the heart |
| Q81351174 | Aortic atherosclerosis and stroke |
| Q51552231 | Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly study. |
| Q40430415 | Arterial thrombosis for the clinician. Pathobiology and emerging concepts. |
| Q37880719 | Arteriosclerosis as a sequela of chronic Chlamydia pneumoniae infection |
| Q28200267 | Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables |
| Q37427170 | Association between circulating leukocyte subtype counts and carotid intima-media thickness in Japanese subjects with type 2 diabetes |
| Q35558976 | Association between job characteristics and plasma fibrinogen in a normal working population: a cross sectional analysis in referents of the SHEEP Study. Stockholm Heart Epidemiology Program |
| Q37886448 | Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors |
| Q44326363 | Association of alcohol consumption with white blood cell count: a study of Japanese male office workers |
| Q80985301 | Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study |
| Q73940083 | Association of hemostatic factors with peripheral vascular disease |
| Q74137858 | Association of plasma viscosity and carotid thickening in a French working cohort |
| Q37882083 | Atherosclerosis due to chronic arteritis caused by Chlamydia pneumoniae: a tentative hypothesis |
| Q36987754 | Biochemical biomarkers are not dependent on physical exercise in patients with spinal cord injury |
| Q35095473 | Biological mechanisms in the relationship between depression and heart disease |
| Q39423575 | Birthweight, adult risk factors and incident coronary heart disease: the Caerphilly Study |
| Q28182392 | Blood polymorphonuclear leukocyte activation in atherosclerosis: effects of aspirin |
| Q31941389 | Blood pressure reactions to the cold pressor test and the prediction of ischaemic heart disease: data from the Caerphilly Study. |
| Q42758524 | Blood rheology and the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio in dyslipidaemic and normolipidaemic subjects |
| Q57700166 | Blood sample stability at room temperature for counting red and white blood cells and platelets |
| Q51232290 | Blood viscometer applying electromagnetically spinning method. |
| Q36541910 | Boiled or filtered coffee? Effects of coffee and caffeine on cholesterol, fibrinogen and C-reactive protein |
| Q54996163 | Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study. |
| Q33658432 | Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke |
| Q51490006 | Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients. |
| Q34609163 | Carotid intima-media thickness and plasma fibrinogen among subjects with metabolic syndrome: Isfahan cohort study, Iran. |
| Q35001664 | Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice |
| Q35660000 | Changes in erythrocyte sedimentation rate, white blood cell count, liver enzymes, and magnesium after gastric bypass surgery |
| Q43571751 | Changes in hemostasis during treatment of hypertriglyceridemia with a diet rich in monounsaturated and n-3 polyunsaturated fatty acids in comparison with a low-fat diet |
| Q52005397 | Changes in hemostatic function at times of cyclic variation in occupational stress. |
| Q78106216 | Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina |
| Q57114252 | Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen |
| Q37880994 | Chlamydia pneumoniae and occlusive vascular disease: identification and characterization |
| Q37867152 | Chlamydia pneumoniae infection in young stroke patients: a case--control study |
| Q73572621 | Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina |
| Q52877803 | Clinical Factors and Angiographic Features Associated With Premature Coronary Artery Disease |
| Q40440943 | Clustering of cardiovascular risk factors: Targeting high-risk individuals |
| Q53267590 | Coagulation and inflammatory markers in Alzheimer's and vascular dementia. |
| Q55387047 | Cocoa Pod Husk Pectin Intended as a Pharmaceutical Excipient Has No Adverse Effects on Haematological Parameters in Sprague Dawley Rats. |
| Q43075140 | Cohort study of the total leukocyte count and periodontal disease among company employees |
| Q39239230 | Comparison of hemorheological changes in patients after acute coronary events, intervention and ambulatory rehabilitation |
| Q73055226 | Comparison of platelet activation in unstable and stable angina pectoris and correlation with coronary angiographic findings |
| Q38745026 | Comparison of viscoelastic properties of cancer and normal thyroid cells on different stiffness substrates. |
| Q35433689 | Composition and classification of human atherosclerotic lesions |
| Q29618549 | Concentrated ambient air particles induce mild pulmonary inflammation in healthy human volunteers |
| Q33911689 | Control of fibrinogen biosynthesis: role of the FFA/albumin ratio |
| Q38857727 | Coronary artery disease and periodontal disease: is there a link? |
| Q51459018 | Correlation between white blood cell count and metabolic syndrome in adolescence. |
| Q46764759 | Correlations between white blood cell count and metabolic syndrome in middle-age Taiwanese |
| Q36832379 | Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? |
| Q35694591 | Counting White Blood Cells from a Blood Smear Using Fourier Ptychographic Microscopy |
| Q24683839 | Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study |
| Q34107288 | Diet and hemostatic factors |
| Q43707625 | Dietary indices of atherogenicity and thrombogenicity and ischaemic heart disease risk: the Caerphilly Prospective Study |
| Q73397582 | Dietary pectin influences fibrin network structure in hypercholesterolaemic subjects |
| Q35752733 | Difference in blood pressure between early and late menopausal transition was significant in healthy Korean women. |
| Q33613250 | Does weight loss reduce plasma fibrinogen? |
| Q79566665 | Early-life and adult socioeconomic status and inflammatory risk markers in adulthood |
| Q34663551 | Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia |
| Q71720381 | Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction |
| Q44086633 | Effect of methyl testosterone administration on plasma viscosity in postmenopausal women |
| Q35802635 | Effects of acipimox on haemorheology and plasma lipoproteins in patients with mixed hyperlipoproteinaemia |
| Q44111022 | Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology |
| Q41875844 | Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients |
| Q41220355 | Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation |
| Q52533093 | Effects of lipids and lipoproteins on thrombosis and rheology. |
| Q71618769 | Effects of n-3 fatty acids and fenofibrate on lipid and hemorrheological parameters in familial dysbetalipoproteinemia and familial hypertriglyceridemia |
| Q53685487 | Effects of smoking on healthy young men's hematologic parameters. |
| Q33530580 | Effects of work place carbon monoxide exposure on blood viscosity |
| Q30491269 | Effort-reward imbalance at work and incident coronary heart disease: a multi-cohort study of 90,164 individuals |
| Q50961272 | Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity. |
| Q73384979 | Elevated inflammatory parameters are associated with lower platelet density in acute myocardial infarctions with ST-elevation |
| Q73714895 | Elevated plasma levels of interleukin-2 and soluble IL-2 receptor in ischemic heart disease |
| Q24793954 | Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes |
| Q74550079 | Exercise and thrombosis |
| Q71827429 | Exercise-induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol-lowering drug therapy with bezafibrate |
| Q33738532 | Expanded network of inflammatory markers of atherogenesis: where are we now? |
| Q74172963 | Experimental thrombosis I: relation with fibrinogen and other haemostatic parameters |
| Q44675558 | Exposure to concentrated ambient air particles alters hematologic indices in humans |
| Q33861058 | Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study |
| Q28220294 | Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review |
| Q43162739 | Fibrinogen |
| Q72049303 | Fibrinogen and Silent Atherosclerosis in Subjects With Cardiovascular Risk Factors |
| Q37201947 | Fibrinogen and cardiovascular disease |
| Q33287487 | Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease |
| Q47363812 | Fibrinogen in obesity before and after weight reduction |
| Q33612628 | Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study |
| Q50907848 | Fibrinogen is an independent marker for thoracic aortic atherosclerosis. |
| Q41094038 | Fibrinogen levels and exercise. Is there a relationship? |
| Q51022348 | Fibrinogen levels in women having coronary angiography. |
| Q47232556 | Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults--the ARIC study. Atherosclerosis Risk in Communities |
| Q37504056 | Fibrinogen: A Marker in Predicting Diabetic Foot Ulcer Severity |
| Q43433246 | Fibrinogen: a link between chronic infection and coronary heart disease |
| Q40744822 | Fibrinogen: an important risk factor for atherothrombotic diseases |
| Q35538771 | Fibrinogen: biochemistry, epidemiology and determinants |
| Q40725303 | Fibrinogen: its emerging role as a cardiovascular risk factor |
| Q52274072 | Fish oil may be an antidote for the cardiovascular risk of smoking. |
| Q34674491 | Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitors |
| Q72690738 | Geographical variations in plasma viscosity and relation to coronary event rates |
| Q74534344 | Glycated hemoglobin levels and their correlation with atherosclerotic risk factors in a Japanese population--the Jichi Medical School Cohort Study 1993-1995 |
| Q36216738 | Haemorheology in exercise and training |
| Q50999715 | Haemorheology in patients with branch retinal vein occlusion with and without risk factors. |
| Q43615154 | Haemostasis in relation to dietary fat as estimated by erythrocyte fatty acid composition: the prime study |
| Q40903888 | Haemostatic factors in coronary heart disease |
| Q40582669 | Haemostatic function, arterial disease and the prevention of arterial thrombosis |
| Q30496316 | Health status as a potential effect modifier of the relation between noise annoyance and incidence of ischaemic heart disease |
| Q92006171 | Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque |
| Q48320416 | Helicobacter pylori infection in subjects with acute ischaemic stroke |
| Q36317666 | Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma |
| Q44061290 | Helicobacter pylori: a new cardiovascular risk factor? |
| Q81700833 | Hemorheological and cardiovascular effects of exercise training in the rehabilitation of elderly patients with chronic obstructive pulmonary disease |
| Q37626485 | Hemorheological disorders in diabetes mellitus |
| Q41675668 | Hemostatic concomitants of syndrome X |
| Q34096078 | Hemostatic effects of third- and second-generation oral contraceptives: absence of a causal mechanism for a difference in risk of venous thromboembolism |
| Q44283340 | High density lipoprotein subfractions and the risk of coronary heart disease: 9-years follow-up in the Caerphilly Study |
| Q51505749 | High-throughput and sensitive particle counting by a novel microfluidic differential resistive pulse sensor with multidetecting channels and a common reference channel. |
| Q28345971 | Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow up |
| Q39482701 | Homocysteine and ischaemic heart disease in the Caerphilly cohort |
| Q28345707 | Homocysteine and ischaemic stroke in men: the Caerphilly study |
| Q36975186 | Hypercoagulability in dogs with blastomycosis |
| Q41341023 | Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease. |
| Q43593882 | Hypertriglyceridemia and other factors associated with plasma viscosity |
| Q40876914 | Hyperviscosity in renal transplant recipients |
| Q40616510 | IL-6 and IL-1 receptor antagonist in stable angina pectoris and relation of IL-6 to clinical findings in acute myocardial infarction |
| Q57885646 | INFLAMMATION, EDEMA, AND PERIPHERAL BLOOD CHANGES IN LUNG-COMPROMISED RATS AFTER INSTILLATION WITH COMBUSTION-DERIVED AND MANUFACTURED NANOPARTICLES |
| Q45879887 | Identification of four novel polymorphisms in the Aalpha and gamma fibrinogen genes and analysis of association with plasma levels of the protein |
| Q30634073 | Idiopathic polypoidal choroidal vasculopathy: a disease with diverse clinical spectrum and systemic associations |
| Q41486331 | Impact of disease on markers of micronutrient status |
| Q35581688 | Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials |
| Q46042286 | Impaired blood rheology and elevated remnant-like lipoprotein particle cholesterol in hypercholesterolaemic subjects |
| Q79329785 | Increase in hepatic mRNA expression of coagulant factors in type 2 diabetic model mice |
| Q30891408 | Increase of arterial thrombosis parameters in chronic Helicobacter pylori infection in mice. |
| Q40733409 | Increased plasma fibrinogen level and future risk of coronary artery disease after repair of abdominal aortic aneurysm |
| Q29618625 | Increased plasma viscosity during an air pollution episode: a link to mortality? |
| Q31915357 | Increased reactivity of platelets induced by fibrinogen independent of its binding to the IIb-IIIa surface glycoprotein: a potential contributor to cardiovascular risk |
| Q73476783 | Induction of cytokine expression in leukocytes in acute myocardial infarction |
| Q73833794 | Infantile obesity: a situation of atherothrombotic risk? |
| Q43428266 | Infection and myocardial infarction |
| Q44431760 | Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm. |
| Q35562469 | Influence of Smoking on Predictors of Vascular Disease |
| Q41635547 | Influence of fibrinogen on cardiovascular disease |
| Q41250408 | Insight into the genetic epidemiology of coronary heart disease |
| Q41333286 | Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study |
| Q51554017 | Interactions between vitamins C and E in human subjects. |
| Q49173840 | Intra-individual variability of fibrinogen levels |
| Q36661798 | Invited commentary: circulating inflammation markers and cancer risk--implications for epidemiologic studies |
| Q43151010 | Iron and coronary heart disease. Control for haematological variables |
| Q40609839 | Iron, magnesium and ischaemic heart disease |
| Q33702283 | Ischaemic heart disease: association with haematocrit in the British Regional Heart Study |
| Q35403968 | Leg length, insulin resistance, and coronary heart disease risk: the Caerphilly Study |
| Q35576140 | Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe |
| Q43479389 | Lipid profile, haemostatic variables and angiographically-defined coronary artery disease: a cross-sectional study in an Irish population |
| Q51022341 | Long-term influence of fibrinogen on initial and recurrent cardiovascular events in men and women. |
| Q49213720 | Longitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease Risk |
| Q34140740 | Low-density lipoprotein apheresis in the treatment of atherosclerosis and other potential uses |
| Q40943042 | Low-density lipoprotein removal methods by membranes and future perspectives |
| Q28389025 | Lung injury after cigarette smoking is particle related |
| Q22241929 | Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association |
| Q42158682 | Measurement of magnetic nanoparticle relaxation time |
| Q90670151 | Methods for counting particles in microfluidic applications |
| Q92860434 | Microfluidic and Nanofluidic Resistive Pulse Sensing: A Review |
| Q51535286 | Nanoliter droplet viscometer with additive-free operation. |
| Q72098206 | Nicotine effects on eicosanoid formation and hemostatic function: Comparison of transdermal nicotine and cigarette smoking |
| Q79444533 | No effect of increased water intake on blood viscosity and cardiovascular risk factors |
| Q35770386 | No evidence for a direct role of Helicobacter pylori and Mycoplasma pneumoniae in carotid artery atherosclerosis |
| Q41526058 | Nonlipoprotein risk factors for coronary heart disease: evaluation and management |
| Q34543079 | Obesity, Glucose Intolerance and Diabetes and Their Links to Cardiovascular Disease. Implications for Laboratory Medicine |
| Q33820733 | Occupational exposure to dust: inflammation and ischaemic heart disease |
| Q47987181 | Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men. |
| Q37872569 | Parameters of inflammation and infection in a community based case-control study of coronary heart disease |
| Q33487898 | Parnaparin. A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disorders |
| Q34977857 | Particles small angle forward-scattered light measurement based on photovoltaic cell microflow cytometer |
| Q33740239 | Pathogenesis and pathology of coronary heart disease syndromes |
| Q34310277 | Pathophysiology of oxidative stress in diabetes mellitus |
| Q42578565 | Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study |
| Q44671129 | Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men. |
| Q41560071 | Pharmacological approaches and strategies for therapeutic modulation of fibrinogen |
| Q58230391 | Physiopathology of Acute Coronary Syndromes |
| Q81689691 | Plasma fibrinogen - are there age-dependent changes? |
| Q41705011 | Plasma fibrinogen and its correlates in elderly Japanese men living in Japan and Hawaii |
| Q50949758 | Plasma fibrinogen concentration in a Chinese population. |
| Q40615591 | Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study |
| Q51596762 | Plasma fibrinogen in relation to serum insulin, smoking habits and adipose tissue fatty acids in healthy men. |
| Q84934992 | Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention |
| Q44648865 | Plasma viscosity as an early cardiovascular risk factor in hirsute women with eumenorrhea or oligomenorrhea |
| Q51534499 | Plasma viscosity in giant cell arteritis. |
| Q44215089 | Plasminogen activator inhibitor-1, fibrinogen, and lung function in adolescents with asthma and obesity. |
| Q24683880 | Platelet aggregation and incident ischaemic heart disease in the Caerphilly cohort |
| Q46837959 | Platelet and white blood cell counts are elevated in patients with the metabolic syndrome |
| Q92241140 | Polymorphisms -455G/A and -148C/T and Fibrinogen Plasmatic Level as Risk Markers of Coronary Disease and Major Adverse Cardiovascular Events |
| Q43591840 | Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u-PA-dependent mechanism |
| Q35224521 | Possibilities of Intervention in Intrinsic and Extrinsic Lysis Programs |
| Q28372218 | Possible mechanisms through which dietary pectin influences fibrin network architecture in hypercholesterolaemic subjects |
| Q37518149 | Postinjury hyperfibrinogenemia compromises efficacy of heparin-based venous thromboembolism prophylaxis |
| Q37765290 | Predicting the no-reflow phenomenon following successful percutaneous coronary intervention. |
| Q36766928 | Prediction of calculated future cardiovascular disease by monocyte count in an asymptomatic population. |
| Q35161148 | Prediction of cardiovascular risk in people with diabetes |
| Q74694147 | Predictive value of preprocedural fibrinogen concerning coronary stenting |
| Q56944455 | Preprocedural white blood cell count and death after percutaneous coronary intervention |
| Q74315449 | Prevalence of factor V Leiden and prothrombin variant G20210A in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction |
| Q77714696 | Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention |
| Q35690807 | Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited |
| Q33168801 | Procoagulatory changes induced by head-up tilt test in patients with syncope: observational study. |
| Q36370881 | Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation |
| Q47438843 | Quadriceps muscle fat infiltration is associated with cardiometabolic risk in COPD. |
| Q30912640 | Recent advances in ischaemic heart disease. |
| Q73091575 | Reduced progression of atherosclerosis in apolipoprotein E-deficient mice with phenylhydrazine-induced anemia |
| Q37878617 | Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study |
| Q73119089 | Relation of admission white blood cell count to long-term outcomes after primary coronary angioplasty for acute myocardial infarction (The Stent PAMI Trial) |
| Q74269420 | Relationship between lipid peroxidation and plasma fibrinogen in middle-aged men |
| Q46647502 | Relationships among iron, protein oxidation and lipid peroxidation levels in rats with alcohol-induced acute pancreatitis |
| Q44981831 | Resonance-thrombography indices of the haemostatic process in relation to risk of incident coronary heart disease: 9 years follow-up in the Caerphilly Prospective Heart Disease Study |
| Q80825005 | Revision in reference ranges of peripheral total leukocyte count and differential leukocyte percentages based on a normal serum C-reactive protein level |
| Q40582640 | Rheological influences on thrombosis |
| Q62760842 | Rheologische Determinanten von Endorgansch�den |
| Q35156864 | Rheology: an overlooked component of vascular disease |
| Q80975481 | Rheumatoid arthritis, periodontal disease and coronary artery disease |
| Q73022835 | Risk factors and outcomes for atherothrombotic disease in French patients: the RIVAGE study. RIsque VAsculaire Group d'Etude |
| Q59352564 | Safety and Impact of Low-Dose Methotrexate on Endothelial Function and Inflammation in Individuals with Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314 |
| Q42027229 | Seismic intensity and risk of cerebrovascular stroke: 1995 Hanshin-Awaji earthquake. |
| Q64130874 | Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III |
| Q46465988 | Serum C-reactive protein and white blood cell count in morbidly obese surgical patients |
| Q40661286 | Should plasma viscosity replace the ESR? |
| Q51135551 | Single-layer microfluidic device to realize hydrodynamic 3D flow focusing. |
| Q43061592 | Smoking and atherosclerotic cardiovascular disease: part II: role of cigarette smoking in cardiovascular disease development |
| Q40794682 | Smoking and hypertension |
| Q24672992 | Smoking, drinking, and other life style factors and cognitive function in men in the Caerphilly cohort |
| Q43577955 | Smoking, other risk factors and fibrinogen levels. evidence of effect modification |
| Q30357463 | Sonic Estimation of Elasticity via Resonance: A New Method of Assessing Hemostasis. |
| Q33613645 | Temperature and risk factors for ischaemic heart disease in the Caerphilly prospective study |
| Q34003176 | Ten-year follow-up for male twins divided into high- or low-risk groups for ischemic heart disease based on risk factors measured 25 years previously |
| Q31129827 | The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases |
| Q57393886 | The G-455A polymorphism of the fibrinogen Bbeta-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women |
| Q30892742 | The Inflammatory Heart Diseases: Causes, Symptoms, and Treatments |
| Q43258124 | The Role of Hematological Indices in Patients with Acute Coronary Syndrome |
| Q35738153 | The aging male: testosterone deficiency and testosterone replacement. An up-date |
| Q43498005 | The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project |
| Q57740621 | The association of chronic cough with the risk of myocardial infarction: the Framingham Heart Study |
| Q34326163 | The biology behind the atherothrombotic effects of cigarette smoke |
| Q42332025 | The clinical significance of whole blood viscosity in (cardio)vascular medicine |
| Q48866640 | The effect of psychosocial stress and risk factors for ischaemic heart disease on the plasma fibrinogen concentration |
| Q46875422 | The effects of experimental hypothyroidism on hemorheology and plasma fibrinogen concentration |
| Q38370885 | The effects of pituitary and thyroid disorders on haemostasis: potential clinical implications |
| Q41728180 | The evidence for exercise-induced inflammation in intermittent claudication: should we encourage patients to stop walking? |
| Q45077803 | The influence of a vegetarian diet on haemostatic risk factors for cardiovascular disease in Africans |
| Q36331473 | The possible role of hemorheology in atherothrombogenesis |
| Q30467949 | The prevalence of hearing impairment and associated risk factors: the Beaver Dam Offspring Study |
| Q53441808 | The relationship between attendance at religious services and cardiovascular inflammatory markers. |
| Q50490065 | The relationship of acute myocardial infarction with or without ST-segment elevation and viscosity. |
| Q41375104 | The relationship of coronary flow to neutrophil/lymphocyte ratio in patients undergoing primary percutaneous coronary intervention |
| Q40866572 | The relative power of heat-precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease: the Caerphilly and Speedwell studies |
| Q37082872 | The role of hemorheological factors in cardiovascular medicine |
| Q34557697 | The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease |
| Q40381228 | The role of platelets in essential hypertension |
| Q43955341 | The third component of the complement (C3) is a marker of the risk of atherogenesis |
| Q92538885 | The uncertain effect of menopause on blood pressure |
| Q30418241 | Thickness dependent effective viscosity of a polymer solution near an interface probed by a quartz crystal microbalance with dissipation method |
| Q42684656 | Thrombin generation and activation of the thrombomodulin protein C system in open heart surgery depend on the underlying cardiac disease |
| Q40877789 | Thromboembolism in cancer. Changing trends |
| Q40759551 | Thrombosis and fibrinolysis in acute myocardial infarction |
| Q30578791 | Tissue-type plasminogen activator antigen and consumption of dairy products. The DESIR study. Data from an Epidemiological Study on Insulin Resistance Syndrome |
| Q34881629 | Traditional laboratory measures of cardiovascular risk in hereditary spherocytosis |
| Q34345582 | Traffic noise and cardiovascular risk: the Caerphilly and Speedwell studies, second phase. Risk estimation, prevalence, and incidence of ischemic heart disease |
| Q90269948 | Transcriptome sequencing of Eospalax fontanierii to determine hypoxia regulation of cardiac fibrinogen |
| Q46720996 | Transdermal HRT and Doppler findings in normotensive and hypertensive postmenopausal patients |
| Q38127353 | Treating thrombus in the coronary arteries |
| Q47987148 | Treatment of severe hypertriglyceridemia lowers plasma viscosity |
| Q28344629 | Tumor necrosis factor receptor levels are associated with carotid atherosclerosis |
| Q35527005 | Two urinary peptides associated closely with type 2 diabetes mellitus |
| Q28196757 | Utility of inflammatory markers in the management of coronary artery disease |
| Q77104469 | Variability in fibrinogen measurements: an obstacle to cardiovascular risk stratification |
| Q51895973 | Weather-induced ischemia and arrhythmia in patients undergoing cardiac rehabilitation: another difference between men and women. |
| Q57241683 | What determines mortality risk in male former cigarette smokers? |
| Q73118426 | [Blood coagulation, genetics and post-angioplasty restenosis] |
| Q51473130 | [Can bariatric surgery cure metabolic syndrome?]. |
| Q73315343 | [Cardiovascular risk factors in diabetic nephropathy] |
| Q73432501 | [Effect of exercise tolerance test on hemostasis in patients with and without coronary heart disease] |
| Q74219044 | [Guidelines of the Spanish Society of Cardiology for cardiovascular disease prevention and cardiac rehabilitation] |
| Q74451978 | [Prognostic value of fibrinogen in patients admitted with suspected unstable angina and non-q-wave myocardial infarction] |
| Q40609826 | beta-Carotene, are we misreading the signals in risk groups? Some analogies with vitamin C. |
| Q51187286 | rHuEPO hyporesponsiveness and related high dosages are associated with hyperviscosity in maintenance hemodialysis patients. |
Search more.